• Day All
• March 28 (Thursday)
• March 29 (Friday)
• March 30 (Saturday)

March 28 (Thursday)

[JS01] Joint Session 01: Asian hematology session I - EBV-associated lymphoid malignancy Room 1

• March 28 (Thursday), 09:00-10:15
• Ki Seong Eom (The Catholic University of Korea College of Medicine, Korea), Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
• 09:00-09:25 Prospective studies for NK/T-cell lymphoma in Asia Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) 09:25-09:50 Chronic active EBV disease: Our challenge to elucidate the pathogenesis Ayako Arai (St. Marianna University School of Medicine, Japan) 09:50-10:15 NK lymphoma genomics Weili Zhao (Shanghai Jiao Tong University School of Medicine, China)

[ES01] Education Session 01: Histiocytic neoplasm Room 2

• March 28 (Thursday), 09:00-10:15
• Nack-Gyun Chung (The Catholic University of Korea College of Medicine, Korea), Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
• 09:00-09:25 Histiocytic neoplasm in pediatrics Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) 09:25-09:50 Histiocytic sarcoma Sungnam Lim (Inje University College of Medicine, Korea) 09:50-10:15 Pathologic characteristics of histiocytic neoplasm Sun Och Yoon (Yonsei University College of Medicine, Korea)

[SS01] Scientific Session 01: Exploring the utilization of innovative technologies Room 3

• March 28 (Thursday), 09:00-10:15
• Young Kyung Lee (Hallym University College of Medicine, Korea), Yoon Hwan Chang (Seoul National University College of Medicine, Korea)
• 09:00-09:25 Elucidating the 3D chromatin landscape of pediatric B-cell acute lymphoblastic leukemia using Micro-C Kajsa Paulsson (Lund University, Sweden) 09:25-09:50 Integrated RNA and protein profiling of B-cell acute lymphoblastic leukemia at single-cell level Sungyoung Choi (Hanyang University College of Medicine, Korea) 09:50-10:15 Leveraging dysregulated signaling networks for therapeutic benefit in myeloproliferative neoplasm Stephen T. Oh (Washington University School of Medicine, USA)

[SS02] Scientific Session 02: The unmet needs in CML - Overcoming the obstacles of the road to cure Room 4

• March 28 (Thursday), 09:00-10:15
• Chul Won Jung (Sungkyunkwan University School of Medicine, Korea), Hawk Kim (Gachon University College of Medicine, Korea)
• 09:00-09:25 Molecular mechanism of primary TKI resistance in CML Jerald Radich (Fred Hutchinson Cancer Center, USA) 09:25-09:50 Targeting leukemic stem cells in CML Mhairi Copland (University of Glasgow, UK) 09:50-10:15 The role of NGS to detect TKI resistance Saeam Shin (Yonsei University College of Medicine, Korea)

[PL01] Plenary Lecture 01 Room 1+2

• March 28 (Thursday), 10:30-11:15
• Seoklae Chae (Dongguk University College of Medicine, Korea)
• 10:30-11:15 Somatic mutations and clonal dynamics in human blood cells Peter J. Campbell (Wellcome Sanger Institute, UK)

[PS01] Presidential Symposium 01 Room 1+2

• March 28 (Thursday), 11:15-12:00
• Seongsoo Jang (University of Ulsan College of Medicine, Korea)
• 11:15–12:00 Lab-on-a-chip in hematology Chong H. Ahn (University of Cincinnati, USA)

[SY01] Satellite Symposium 01: Janssen Room 1

• March 28 (Thursday), 12:15-13:05
• Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
• 12:15-13:05 Treatment of newly diagnosed multiple myeloma: Focus on daratumumab combination Elena Zamagni (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy)

[SY02] Satellite Symposium 02: Astrazeneca Room 2

• March 28 (Thursday), 12:15-13:05
• Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
• 12:15-13:05 The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH Sung-Hyun Kim (Dong-A University College of Medicine, Korea)

[SY03] Satellite Symposium 03: Astellas Room 3

• March 28 (Thursday), 12:15-13:05
• Hee-Je Kim (The Catholic University of Korea College of Medicine, Korea)
• 12:15-13:05 Treatment strategies for elderly AML with FLT3-mutation, entering the era of FLT3 Inhibitors Naoko Hosono (University of Fukui, Japan)

[SY04] Satellite Symposium 04: Roche Room 4

• March 28 (Thursday), 12:15-13:05
• Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
• 12:15-13:05 Advances in the treatment paradigm with bispecific antibodies Wendy Osborne (Newcastle University, UK)

[JS02] Joint Session 02: EHA-KSH Joint Symposium - Multiple Myeloma Room 1

• March 28 (Thursday), 15:30-16:45
• Jin Seok Kim (Yonsei University College of Medicine, Korea), Meral Beksac (Ankara Liv Hospital, Türkiye)
• 15:30-15:46 Dynamic assessment of risk in multiple myeloma Meral Beksac (Ankara Liv Hospital, Türkiye) 15:46-16:02 PET/CT for risk stratification in multiple myeloma Joon Ho Moon (Kyungpook National University School of Medicine, Korea) 16:02-16:18 Bone marrow inflammation in multiple myeloma Tom Cupedo (Erasmus MC Cancer Center, The Netherlands) 16:18-16:34 Single-cell analysis in multiple myeloma Sung-Soo Park (The Catholic University of Korea College of Medicine, Korea)

[SS03] Scientific Session 03: Wise perspective on new approaches in hemophilia Room 2

• March 28 (Thursday), 15:30-16:45
• Eun Jin Choi (Daegu Catholic University School of Medicine, Korea), Young Shil Park (Kyung Hee University College of Medicine, Korea)
• 15:30-15:55 Approaches to treat people with hemophilia: What’s new and what’s not? Leonard Valentino (The National Bleeding Disorders Foundation (NBDF) , USA) 15:55-16:20 Prospects and challenges of gene therapy for hemophilia Alok Srivastava (Christian Medical College, India) 16:20-16:45 Exploring personalized tailored hemophilia treatment Jeong A Park (Inha University College of Medicine, Korea)

[SS04] Scientific Session 04: For the next generation CAR-T cells Room 3

• March 28 (Thursday), 15:30-16:45
• Seok-Goo Cho (The Catholic University of Korea College of Medicine, Korea), Je-Jung Lee (Chonnam National University Medical School, Korea)
• 15:30-15:55 CD7 CAR-T therapy for treating hematological maligancies Peihua Lu (Lu Daopei Hospital, China) 15:55-16:20 Development of a novel anti-CD19 CAR-T cells in B cell lymphoma Dok Hyun Yoon (University of Ulsan College of Medicine, Korea) 16:20-16:45 CAR T cells for treatment of T cell malignancies Paul M. Maciocia (Cancer Research UK , UK)

[SS05] Scientific Session 05: Deepened understanding of AML using multi-omics approaches Room 4

• March 28 (Thursday), 15:30-16:45
• Hyeoung-Joon Kim (Chonnam National University Medical School, Korea), Myung-Shin Kim (The Catholic University of Korea College of Medicine, Korea)
• 15:30-15:55 Navigating cancer complexities via single-cell omics and AI Manoj Bhasin (Emory University, USA) 15:55-16:20 Targeting the developmental heterogeneity of human acute myeloid leukemia Shanshan Pei (Zhejiang University, China) 16:20-16:45 Mutational profile in Korean AML patients Jae-Sook Ahn (Chonnam National University Medical School, Korea)

[SS06] Scientific Session 06: Insights into lymphoma pathobiology Room 1

• March 28 (Thursday), 16:55-18:10
• Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea), Gyeong-Sin Park (The Catholic University of Korea College of Medicine, Korea)
• 16:55-17:20 Germinal center in the genesis of lymphomas Laura Pasqualucci (Columbia University, USA) 17:20-17:45 Genomics of follicular lymphoma: Clinical implications? Robert Kridel (University Health Network, Canada) 17:45-18:10 Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression Jin Ho Paik (Seoul National University College of Medicine, Korea)

[SS07] Scientific Session 07: Profound understanding of diagnosis and therapy in MDS Room 2

• March 28 (Thursday), 16:55-18:10
• Yoo Jin Kim (The Catholic University of Korea College of Medicine, Korea), Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
• 16:55-17:20 Molecular alterations and clinical implications in MDS Yasushi Miyazaki (Nagasaki University, Japan) 17:20-17:45 Recent advances and future therapeutic strategies in MDS Guillermo Garcia-Manero (The University of Texas MD Anderson Cancer Center, USA) 17:45-18:10 Current diagnostic challenges of MDS In-Suk Kim (Pusan National University Yangsan Hospital, Korea)

[SS08] Scientific Session 08: Leukemogenesis in children and adults Room 3

• March 28 (Thursday), 16:55-18:10
• Kyung Ha Ryu (Ewha Womans University College of Medicine, Korea), Hoon Kook (Chonnam National University Medical School, Korea)
• 16:55-17:20 RUNX1-FPDMM natural history study at NIH Pu Paul Liu (National Institutes of Health, USA) 17:20-17:45 Clinical impact of DDX41 mutations in myeloid neoplasms Talha Badar (Mayo Clinic, USA) 17:45-18:10 Discovery of new regulators in hematopoietic stem cells and malignancies Dongjun Lee (Pusan National University School of Medicine, Korea)

[ES02] Education Session 02: Basics for trainees (Kor) Room 4

• March 28 (Thursday), 16:55-18:10
• Inho Kim (Seoul National University College of Medicine, Korea), Jaewoo Song (Yonsei University College of Medicine, Korea)
• 16:55-17:20 Overview of lymphoma classification Tae-Jung Kim (The Catholic University of Korea College of Medicine, Korea) 17:20-17:45 What's new in AML classification Hee Sue Park (Chungbuk National University College of Medicine, Korea) 17:45-18:10 Recent update of MDS classification MiYoung Kim (University of Ulsan College of Medicine, Korea)